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Abstract 
 
The use of traveling wave ion mobility mass spectrometry (TWIMS) is evaluated in 
conjunction with, and as a possible alternative to, conventional LC-MS(/MS) methods 
for the separation and characterization of drug-like compounds and metabolites. As 
a model system we use an in vitro incubation mixture of the chemotherapeutic agent 
melphalan, which results in more than ten closely related hydrolysis products and 
chain-like oligomers.  
Ion mobility as a filtering tool results in the separation of ions of interest from 
interfering ions, based on charge state and shape/size. Different classes of chemical 
compounds often display different mobilities even if they show the same LC behavior 
± thereby providing an orthogonal separation dimension. Small molecules with 
identical or similar m/z that only differ in shape/size (e.g. isomers and isobars, 
monomers/dimers) can also be distinguished using ion mobility. Similar to retention 
times and mass-to-charge ratios, drift times are analyte-dependent and can be used 
as an additional identifier.  
We find that the compound melphalan shows two different drift times due to the 
formation of gas-phase charge isomers (protomers). The occurrence of protomers 
has important implications for ion mobility characterization of such analytes, and also 
for the interpretation of their fragmentation behavior (CID) in the gas phase. 
 
 
Keywords: LC-MS; Tandem MS; Ion mobility; Isomer separation; Protomers; 
Melphalan 
 
 
  
Highlights 
 
x Ion mobility is easily integrated in existing LC-MS methods without loss 
of information or increase in analysis time 
 
x Post-acquistion charge-state filtering and extraction of otherwise hard 
to detect signals  
 
x Rapid classification of analyte classes based on ion mobility behaviour 
(combination of size/shape and charge state) 
 
x Resolution of overlapping signals in addition to or as a faster replace-
ment of LC separation 
 
x Detection of gas-phase charge site isomers (protomers) in ion mobility 
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1. Introduction 
 
LC-MS/MS is one of the most powerful and favored analytical techniques for the 
analysis of small molecules in complex matrices. Nonetheless, the analysis of 
samples containing co-eluting compounds and analytes with similar or identical MS 
properties (mass, fragmentation and/or isotope patterns) remains a frequent 
challenge. One of the breakthrough analytical technologies in the last decade is ion 
mobility-mass spectrometry (IM-MS) [1-3]. As a gas-phase separation technique, IM 
characterizes ions based on their collision cross-section (CCS; a parameter related 
to WKH LRQ¶V rotationally averaged size, shape, total charge and charge distribution). 
An acceleration voltage is applied along WKH LRQ¶V IOLJKW SDWK WKURXJK the drift cell 
filled with neutral buffer gas [4]. Due to friction, i.e. collisions with the gas molecules, 
the ions reach a characteristic velocity, and the time it takes for an ion to pass 
through the cell is called the drift time (td). The type of drift gas used, typically He or 
N2, has a significant effect on the resolving power of ion mobility [5,6]. Moreover, the 
use of polarizable drift gases (e.g. N2 or CO2) can lead to separation of charge site 
isomers, i.e. (de)protomers, of an otherwise identical analyte molecule (see below).  
Ion mobility itself has proven to be effective e.g. for detection of narcotics and 
explosives [7,8]. Although its hyphenation with MS in commercial instrumentation is 
a more recent development, it has already created new possibilities for the 
characterization of some classes of small molecules and metabolites [9-11]. Specific 
examples are the separation of isomeric disaccharides [12-14] and metal(-ligand) 
complexes [15-17] or the characterization of carbohydrate, glycan and lipid 
structures [18-23]. Particular interest recently focused on the phenomenon of 
alternative charge sites in small molecules that are observed in the gas phase, i.e. 
the observation of protonation site isomers (protomers) [24-26]. The routine use as a 
separation technique is however still in its infancy, and the added benefit (if any) of 
combining IM with LC-MS/MS has not been studied systematically. Here we utilize 
traveling wave ion mobility spectrometry (TWIMS), which has been described 
previously [27-29].  
 
An important application of TWIMS in the context of complex samples is background 
filtering. Often samples contain unwanted additives such as salts, plasticizers or 
interfering analytes that hinder the detection of the compounds of interest. Even 
though ion suppression may still occur in the electrospray process, IM-MS can reveal 
specific analyte ions which are present in the spectra but difficult to discern, by 
separating them from interfering background ions based on their charge and 
shape/size [30,31]. Such filtering can also be performed post-acquisition, provided 
that the data were recorded in ion mobility mode [32].  
Given that LC separations have a timescale of minutes and time-of-flight (TOF) 
detection occurs in microseconds, IM is easily integrated with its millisecond regime 
without affecting the timescale of the existing LC-MS/MS method, by adding an extra, 
orthogonal separation dimension. Relatively few studies have been published on the 
use of LC-IM-MS/MS so far [33-38], but this number is expected to increase 
considerably in the next years. While retention time (tR), drift time (td) and mass-to-
charge (m/z) provide key analytical determinants (e.g. polarity, shape/size and mass), 
the characterization of compounds solely based on these parameters could lead to 
incorrect assignment, and is often considered insufficient in practice. Fragmentation 
by MS/MS on the other hand is generally employed to obtain structural information 
[39,40], and we also investigate its use here together with ion mobility analysis. 
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Recently IM-MS/MS has been used to enhance peptide detection [41], study the 
fragmentation patterns of drug metabolites [42] and (de-)protomers [24-26,43,44]. 
 
The present study focuses on the efficiency and versatility of ion mobility as an 
adjunct to LC-MS/MS methods, by using a model compound mixture with moderate 
analytical complexity. We previously investigated melphalan (L-phenylalanine 
mustard; see Figure 1), an alkylating agent which is used in the treatment of cancer 
[45,46]. Several studies have been published discussing its (pharmaco)kinetics, 
binding to DNA and proteins [47-50], and its clinical applications. In aqueous solution, 
melphalan forms two major hydrolysis products [51,52] in vitro, mono- and dihydroxy 
melphalan, as well as chain-like oligomers [53]. In total, more than ten closely related 
degradation products were characterized before (Table 1). Understanding the 
complexity of these drug-related compounds is essential for our ability to accurately 
determine drug levels in patients, and particularly also for the quantitation of the 
active form of the drug in different sample matrices. 
 
 
 
2. Materials and methods 
 
Caution: melphalan, degradation products and oligomers are carcinogenic and 
should be handled with care. 
 
2.1 Chemicals 
Melphalan (Mel; min. 95 %) and sodium formate (HPLC, > 99.0 %) were purchased 
from Sigma̺Aldrich (Bornem, Belgium). Acetonitrile (ACN; HPLC grade for gradient 
analysis) and formic acid (FA; 99+ %) were obtained from Acros (Geel, Belgium). 
Reverse osmosis (RO) water was prepared using a Silex water filtering system from 
Eurowater (Nazareth-Eke, Belgium). Leucine Enkephalin (Leu-Enk) was obtained 
from Waters (Manchester, UK). 
 
2.2 Incubation of melphalan 
A 1 mg/mL solution of Mel was prepared using RO water, and vortexed and 
sonicated to improvHVROXELOLW\7KLVVROXWLRQZDVLQFXEDWHGDWÛ&IRUKXVLQJD
Thermomixer (Eppendorf, type 5436). Samples were centrifuged for 4 minutes at 
14.000 rpm (Eppendorf miniSpin plus) to remove particles. 
For direct infusion experiments, the sample was diluted 1:1 with a 50:50 ACN:RO 
(0.1% formic acid; FA) solution. 
 
2.3 Instrumentation 
2.3.1 nanoAcquity UPLC 
A binary gradient was developed on a Waters nanoAcquity UPLC system (Milford, 
MA, USA). Trapping column: 180 µm x 20 mm; 5 µm Symmetry C18; analytical 
column: 100 µm x 100 mm; 1.7 µm Acquity BEH130 C18 column (both Waters; 
Manchester, UK&ROXPQWHPSHUDWXUHZDVNHSWDWÛ&7KHJUDGLHQWPHWKRGXVHG
acidified H2O (solvent A; 0.1 % FA) and ACN (solvent B) for analysis as well as for 
wash purposes. The gradient had a run time of 35 minutes, starting with 1.00 minute 
of on-column focusing. The gradient went from 1 to 50% B over 5.00 minutes, 
followed by 0.99 minutes of washing (99 % B) and 24 minutes of equilibration at 
initial conditions. Injection: 5 µL full loop (overfill factor 1). 
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2.3.2 Synapt G2 HDMS 
In this study we used a Waters Synapt G2 HDMS mass spectrometer equipped with 
TWIMS technology. The TWIMS cell is located after the quadrupole (Q), between 
two collision cells (trap and transfer cell) and before the TOF [29]. Key features of 
this setup are the possibility to select a precursor ion in the quadrupole, perform 
collision-induced dissociation (CID) either prior to or post-IM-MS separation, and 
detect the accurate masses of the (fragment) ions in the TOF.  
A chip-based NanoMate source (Advion, Ithaca, NY, USA) was used for positive ESI. 
The NanoMate was connected with the nanoAcquity pump using an LC-coupler. A 
spray voltage of 1.7 kV was applied. Source and desolvation temperatures were 80 
and 60 °C respectively. For direct infusion experiments, a source temperature of 
60 °C was used. Prior to the experiments, the instrument was calibrated for the 
appropriate mass range using sodium formate solution. In addition, for some 
experiments a solution of Leu-Enk was sprayed using a dual spray setup, and mass 
spectra were corrected by using the Leu-Enk (m/z 556.2771) signal as lock mass. 
The parameters for the experiments without IM are: resolution mode, m/z range of 
50-700, sample and extractor cone voltage of 25 V and 3 V, trap bias of 2 V, trap 
and transfer CE of 4 V and 0 V, respectively. The parameters for the experiments 
with IM are: resolution mode, m/z range of 50-600, 500-600 or 50-1000, sample 
cone voltage of 20-40 V, extraction cone voltage of 3 V, trap bias of 40-45 V, IMS 
wave velocity of 500-1400 m/s, IMS wave height of 40 V, He and IMS (N2) gas flow 
of 180 mL/min and 90-100 mL/min, trap and transfer CE of 4 V and 0 V. Scan time: 
1.0 sec for direct infusion and 0.500 sec for LC-coupling experiments. Interscan time: 
0.024 sec. 
 
2.4 Data acquisition 
Data is acquired in multiple dimensions: LC, IM, MS and MS/MS, and for the 
purpose of this study extracted and displayed in 2 dimensions. Although several 
combinations are possible, the most relevant is IM/MS, next to LC/MS and LC/IM. 
Figure 1 visualizes the data acquisition for an LC-IM-MS/MS experiment. 
For post-acquisition data filtering, a melphalan incubation sample is directly infused 
into the mass spectrometer without inclusion of an LC separation step. The 
separation in the TWIMS cell was optimized to give transmission for a wide m/z 
range. This allows detecting melphalan monomers, dimers and trimeric compounds. 
Data acquisition times, after optimization, are less than 5 minutes per sample. 
Ion mobility vs. m/z data were exported to MassLynx without prior specific mass, 
charge or drift time selection (unless stated otherwise). In MassLynx, sequential m/z 
and td ³ILOWHUV´ DUH DSSOLHG ZKLFK HQDEOH PRUH WDUJHWHG GDWD H[WUDFWLRQ in the 
dimensions of interest. Practically, peaks in the mass spectrum or drift time plot are 
selected at FWHM, i.e. extracted drift time and m/z profiles are corresponding to the 
upper half around the apex of those peaks. 
Isomer separation experiments comprise: the injection of the incubation mixture of 
melphalan, an LC separation using (nano)UPLC, IM separation and high-resolution 
MS detection. IM-MS parameters are fine-tuned for specific sets of ions (e.g. 
isomers) with the aim to obtain baseline-separated peaks in ion mobility. Driftscope 
software is used to extract and export the drift time plot accounting for all ions which 
elute at a given retention time.  
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3. Results and discussion 
 
3.1 Post-acquisition data filtering 
In a first set of experiments, we investigate the advantages of ion mobility for the 
separation of complex mixtures without the use of LC. Data analysis comprises the 
use of DriftScope software to plot drift times (td) vs. m/z values (see Figure 2; centre) 
and create an ion mobility plot. This representation is suitable for obtaining an 
overview of the types of analytes present and to discover trends in the acquired data. 
Grouped signals (i.e. within ellipses) represent ions with similar characteristics (mass, 
shape/size and charge). Exporting signals within these ellipses together with their 
underlying drift times results in spectra with specific charge states, as demonstrated 
in Figure 2a-d. Singly and doubly charged ions can easily be distinguished (Figures 
2a and 2b). Based on their mass and isotope pattern, singly charged signals can be 
assigned to monomers (see Figure 2a) as well as di- and trimers (i.e. melphalan 
oligomers; see Figures 2c and d). For the doubly charged ions, oligomers from di- up 
to hexamers are observed. 
When comparing the extracted mass spectrum of drift-time selected 2+ ions with the 
original, complete spectrum (data not shown but similar to Figure 2a), the signal 
intensity of the doubly charged ions appears enhanced (see Figure 2b) as the much 
stronger singly charged ions are now filtered out. Similarly, the signal-to-noise ratio 
of singly charged dimers and trimers appears greatly improved after selection of their 
signals in the 2D IM plot (enhanced spectra in Figure 2c and d; extracted from the 1+ 
ellipse in the center plot), demonstrating the power of ion mobility data filtering for 
targeted analyses. 
 
A more detailed analysis of the ion mobility data (see Figure 3; zoom from Figure 2) 
shows three drift time signals at the same m/z 269: 2.66 ms, 3.15 ms and 3.90 ms. 
The complete drift time trace is indicated as a dotted line (left, vertical panel), while 
the superimposed colored profiles show the individual, extracted drift times. The 
signal at 3.90 ms accounts for a singly charged ion with m/z 269.1584, which can be 
assigned to the DOH monomer (M3). The two low-intensity signals at 2.66 ms (N3) 
and 3.15 ms (M5a/b) are identified as 2+ ions based on their isotope patterns (data 
not shown), but being at m/z 269 they must also be dimeric. These doubly charged 
dimers show significantly different gas-phase characteristics (e.g. shape or size), 
and are therefore mobility-resolved. Similar observations were made for the other 
doubly charged dimers (see Table 1). We previously discovered the existence of 
nine unique dimeric compounds [53], which can be categorized into two classes: M-
type and N-type dimers, with the N-type dimers formed after elimination of water 
from an M-type analogue. These data highlight how ions with very similar m/z values 
can have distinctly different associated ion mobility signals, facilitating their 
separation and identification. 
 
3.2 Isomer separation 
The main goal in the second set of experiments is to compare the performance of LC 
with IM separation for specific sets of ions (e.g. isomers). Previously, an LC-MS/MS 
method was developed to analyze the complex mixture of isomeric and isobaric 
melphalan-derived compounds. Baseline separation was achieved then for all 
compounds using (nano-)UPLC, and both MS/MS experiments and accurate mass 
determination were used for their identification [53]. With IM-MS implemented here in 
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D³SDQRUDPLF´PRGH to cover species up to dimers, all ions in the acquired m/z-range 
are equally transmitted and detected in the mass spectrometer; but the settings do 
not yield the best possible IM resolution for each individual species.  
Since the resolving power of the LC and IM methods is of particular interest here, we 
focus on compounds with the same nominal or exact masses, which pose the 
biggest analytical challenge. The separation of three singly charged melphalan 
dimers at m/z 537 (M5a/b and N3; see Figure 3 and 4a) is an interesting example. 
Extracting the drift time profile of each compound and their superposition reveals 
only minor differences (Figure 4b-c). Two singly charged, isobaric ions (M5b and N3) 
show virtually identical ion mobility behavior, whereas the third ion (M5a), which is an 
isomer of M5b, appears at a slightly longer drift time. In this case, ion mobility alone 
is only able to separate one of the isomers from the other two ions, whereas LC was 
able to separate all three from each other. The series of doubly charged [M+2H]2+ 
and [N+2H]2+ ions in Figure 2 (red/white dots in the 2+ ellipse) on the other hand, 
which also contains the M5a/b and N3 isomer/isobar pairs, are all drift-time separated. 
Tintaru et al. made a similar observation for poly(amidoamine) dendrimers [54], that 
a higher charge state may allow for better IM separation when compared to the 
singly charged ions. Development of a targeted method, which aims to replace LC 
with IM separation should therefore include higher charge states of the analyte. 
 
3.3 Observation of multiple drift times for melphalan  
During direct infusion IM-MS experiments, not one but two peaks are observed in the 
ion mobility spectrum for melphalan (m/z 305; see Figure 1 and 3). Both ions appear 
at m/z 305.0824, with drift times of 4.18 ms and 4.61 ms respectively. On the other 
hand, LC separation results in only one retention time for this molecule (see Figure 
1). Analysis of a melphalan sample using 1H-NMR reveals no major impurities (data 
not shown) that could cause a second drift time to be observed for m/z 305. This 
indicates that in solution only one form (e.g isomer) of melphalan is likely to be 
present. Therefore, the presence of a second drift time must be inherent to the gas-
phase properties of the molecule and/or the ion mobility separation itself.  
A study by Kaufmann et al. [55] reports on the existence of two ion types for the 
pesticide norfloxacin7KHVH µLVREDULF LRQV¶KDYH LGHQWLFDO UHWHQWLRQ WLPHVDQGH[DFW
masses, but appear to have different gas-phase properties. Based on IM and MS/MS 
data, they conclude that these ions only differ in the site of protonation, and are thus 
UHIHUUHG WR DV µSURWRPHUV¶ 2WKHU VWXGLHV KDYH UHSRUWHG RQ WKH REVHUYDWLRQ RI
protomers for different analytes using both MS as well as other techniques such as 
gas-phase infrared photodissociation (IRPD) spectroscopy [56-58]. We also explain 
the observation here of two drift times for melphalan by the presence of charge 
isomers (protomers) in the gas phase [26].  
 
3.4 Structure assignment using MS/MS 
While compounds can in many cases be identified based on their retention time (LC) 
or drift time (IM), the characterization of (unknown) structures requires MS/MS 
fragmentation data. MS/MS can be performed either in the trap and transfer cell of 
the instrument, before and after ion mobility separation, respectively. Transfer CID 
spectra of melphalan are shown in Figure 1, and a corresponding ion mobility plot-
like visualization for the two melphalan protomers is given in Figure 5. The fragment 
ions are drift time-aligned here, since they originate from different, mobility-resolved 
precursor ions. These data show that both types of melphalan ions (protomers) have 
unique and characteristic fragmentation patterns. Most fragment ions are observed 
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at the drift time of the slower ion (4.61 ms), which is more easily fragmented. 
Characteristic for this drift time is the loss of NH3, which generates a fragment ion at 
m/z 288, and also hints at -NH2 protonation for this protomer. The faster ion (4.18 
ms) results in fewer fragments, with a unique ion observed at m/z 168. This protomer 
represents melphalan protonation on the second nitrogen atom on the mustard side 
(see structures in Figure 5). 
In contrast, ³QRUPDO´CID spectra which are recorded without, or prior to, ion mobility 
separation (e.g. trap CID) contain fragments from both protomers together, i.e. they 
show a weighted sum of the fragmentation spectra for each of the two protomer ions 
(also see Figure 5). As the experimental parameters of electrospray ionization as 
well as the sampling interface ³VRXUFH´ DUH PDMRU IDFWRUV LQ WKH formation of 
alternate protonation isomers, the relative abundance of protomers and the 
corresponding fragment intensities in CID will appear to be quite variable, precluding 
the use of MS/MS spectral libraries. 
 
 
 
4. Conclusions and Outlook 
 
Here we investigate the complementarity of LC and IM for the study of drug-like 
compounds, and show the benefits and limitations of adding ion mobility to the LC-
MS/MS method toolbox; with an emphasis on how it can improve data quality and 
information content of complex samples. In vitro incubation samples of the alkylating 
agent melphalan result in complex spectra of ions with different charge states and 
overlapping isotopic and fragmentation patterns. We show that the addition of IM 
improves and simplifies the acquired data and enables post-acquisition data filtering. 
Data that have been acquired in mobility mode, but not analyzed in that dimension, 
can still be re-analyzed later should interferences become apparent.  
While leaving the ESI process unaffected, ion mobility can overcome issues of 
overlapping peaks by adding an orthogonal separation. It also enables improved 
data visualization, resulting in cleaner and more information-rich MS spectra. Ion 
mobility is used here for charge-state filtering and the separation of different groups 
of compounds. By enabling software-based filtering of ions with distinct drift times or 
drift time ranges, IM-MS simplifies the interpretation of the mass spectra. Visualizing 
these data in a 2D ion mobility plot facilitates the observation of different molecular 
classes and functional groups. Since electrospray ionization (ESI) can generate 
multiply charged ions, overlapping mono- and oligomer peaks at the same m/z result 
in complex and only partly resolved mass spectra. Without the use of an additional 
separation step (e.g. ion mobility), interpretation of LC-MS data can be difficult due to 
overlapping isotope and fragmentation patterns and the wide concentration range of 
the analytes. 
 
Unexpectedly, two drift times are observed for singly charged melphalan (m/z 305). 
The two species are only visible using IM-MS, and drift time-aligned fragmentation 
experiments give insight into their structural properties. We explain these findings 
with the presence of protonation site isomers (protomers), which originate from the 
ionization and desolvation process in the interface of the instrument, and therefore 
have no physiological relevance as a functional analyte. Protomer separation is 
thought to be the result of interactions between the dipole moment of the ion, 
resulting from its charge distribution, and polarizable gas molecules, which lead to an 
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additional retardation of ion movement through the drift gas [43,44,55,59]. A more 
detailed study of melphalan protomers has been published recently [26]. 
The possibility of alternative protonation forms is relevant for all LC analyses, which 
use MS/MS detection. Protomers are produced in the ESI source with varying 
intensities according to the parameters used, but only become visible in combination 
with IM. As they also fragment differently, this leads to somewhat unpredictable 
variations in fragment intensities, and is one important reason why ESI CID spectral 
libraries (similar to EI fragmentation libraries standardized at 70eV) are not popular. 
 
Due to the potential of saving considerable analysis time, it could be advantageous 
to substitute LC with IM separation. Our data show that care should be taken though, 
as isobaric melphalan dimers are only partially drift-time resolved as 1+ ions, while 
the 2+ ions on the other hand can be separated by direct infusion IM-MS. As ESI 
usually produces more than one charge state, at least for larger analytes, a targeted 
IM-MS method utilizing higher charge states may well be able to replace LC-MS in 
some cases. The separation power of IM-MS is highly dependent on the physico-
chemical properties of the analytes, particularly their size/shape or compactness 
³GHQVLW\´. Using the current methods and/or technologies, baseline ion mobility 
separation could not be achieved here for some closely related compounds (e.g. 1+ 
melphalan dimers, isomers and isobars). Hence, the resolving power of the LC 
separation is still essential. For now, we are convinced that LC and IM should be 
regarded as complementary separation technologies. Ion mobility alone should not 
(yet) be seen, at the current resolving power (dtd/'dtd) of 40 or less, as a faster 
substitute for liquid chromatography. 
 
Nonetheless, the addition of IM to an existing LC-MS(/MS) method increases sample 
information and confidence of analyte identification significantly. MS/MS is essential 
to identify unknown compounds and to obtain important structural information, but 
baseline LC and/or IM separation of individual species should be achieved. The 
possibility to perform LC and IM separations orthogonally, either separately or in 
combination, is a major advantage over the current LC-MS and MS/MS approaches. 
Also, the IM-Q-TOF setup offers new possibilities for precursor-selective MS/MS, 
such as the ability to perform drift time-aligned fragmentation in the transfer cell of 
the instrument. Precursor ions are fragmented simultaneously and corresponding 
fragments identified based on their drift time, which they share with the precursor, 
instead of sequential mass-to-charge (i.e. quadrupole) selection of all ions of interest. 
Since no ions are lost during ion mobility separation, the data can be recorded in ion 
mobility mode and re-analyzed at a later stage when focusing on new compounds in 
the already recorded sample (e.g. drugs of abuse). As a result of this drift time-based 
selection, the method is also faster than sequential m/z selection using a quadrupole. 
Other drift gases can be used to increase the IM separation, similar to the use of LC 
columns with different stationary phases. New types of mobility analyzers (high-
pressure multiplexed drift tubes and trapped ion mobility in funnels) are also now 
becoming available commercially, with a resolving power of up to 400. We are 
convinced that the addition of ion mobility separation will prove useful for the 
analysis of many complex mixtures of small molecules. The full power of an LC-IM-
MS/MS approach will be developed in future work. 
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Figures 
 
Figure 1 
Visualization of an LC-IM-MS/MS experiment. Data is acquired in multiple dimensions: LC, IM, MS and MS/MS. LC peak and drift 
time profile are displayed for melphalan (M1; m/z 305) and the dimer M7 (m/z 573; for compound labels see Table 1). For 
melphalan, two different drift times are observed and each one results in a different MS/MS spectrum. In the CID spectrum of the 
td=4.61 ms species, the melphalan precursor ion is fully fragmented (no m/z 305 peak left; middle spectrum in right column). 
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Figure 2 
Ion mobility plot (centre) and extracted mass spectra for different charge states (a-b) 
and different melphalan oligomer sizes (c-d). The TIC mass spectrum looks similar to 
(a), as singly charged ions are observed as very intense signals while the higher 
charge states are at much lower intensity. IM separation and charge state extraction 
(b) results in better visualization of the 2+ ions (b). Two types of dimers are 
observed: the M-type (white dots) and N-type (red dots) dimers, which are formed 
after elimination of water from an M-type analogue. Both dimers are only separated 
as 2+ ions, but not as 1+ ions.. 
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Figure 3 
Enlarged section of the IM plot (Figure 2) with extracted drift times and m/z values 
for m/z 269 and m/z 305 ions (left panel). The dotted line represents the entire drift 
time spectrum, while individual signals are normalized to 100% intensity separately 
and shown superimposed in color. M-type ions are shown by white dots, N-type ions 
by red dots. The size of each dot gives an indication of the signal intensities. 
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Figure 4 
(a) Partial structures of the m/z 537 dimers from Figure 3 (M5a/b and N3). The 
subscript 'a/b' refers to the two observed isomers. Chemical formulae, retention 
times and drift times for the isobaric and isomeric compounds can be found in Table 
1. (b) LC chromatogram and (c) superimposed drift time signals for the m/z 537 
dimers, i.e. M5a/b and N3. Good LC separation is achieved for all compounds. After 
optimization of the IM parameters for this specific set of ions, only a partial IM 
separation is achieved for the M5a and M5b isomers. 
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Figure 5 
Ion mobility plot-like visualization of the fragmentation spectra for transfer CID 
experiments of melphalan. Each protomer is drift-time aligned and has a distinct 
fragmentation pattern with unique fragment ions (e.g. m/z 288 and m/z 168). The 
MS/MS data hint at -NH2 protonation for the slower ion (td= 4.61 ms; black box) and 
protonation of the second nitrogen atom on the mustard moiety for the faster ion (td= 
4.18 ms; red box). The MS/MS spectrum shows trap CID products of melphalan 
similar to those acquired on instruments lacking IM (e.g. tandem quadrupole MS). 
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Table 1 Overview of the calculated ions that are expected for melphalan (M1) and its two monomeric hydrolysis products, 
monohydroxymelphalan (MOH; M2) and dihydroxymelphalan (DOH; M3), together with the dimeric compounds (M4-M7 and N1-
N3).The subscript 'a/b' refers to the observed isomers (see Figure 5). Experimental CCS values are those of the singly charged 
ions. 
Compound Class Chemical formula 
Calculated m/z Structural 
tR (min) 
td (ms) 
[M+H]1+ [M+2H]2+ isomers [M+H]1+ [M+2H]2+ 
M3 Monomer C13H20O4N2Cl0 269.1502 - 1 5.05 3.90 - 
M2 Monomer C13H19O3N2Cl1 287.1163 - 1 8.95 4.07 - 
M1 Monomer C13H18O2N2Cl2 305.0824 - 1 10.07 
4.18 - 
4.61 - 
N1 Dimer C26H36O6N4Cl0 501.2715 251.1396 1 8.54 6.56 2.55 
N2 Dimer C26H35O5N4Cl1 519.2376 260.1227 1 9.05 6.78 2.60 
M4 Dimer C26H38O7N4Cl0 519.2820 260.1449 1 8.36 6.78 3.04 
N3 Dimer C26H34O4N4Cl2 537.2037 269.1058 1 9.50 7.05 2.66 
M5a/b Dimer C26H37O6N4Cl1 537.2481 269.1280 2 8.82b / 8.96a 7.05a/b 3.15 
M6a/b Dimer C26H36O5N4Cl2 555.2142 278.1110 2 9.49a / 9.66b 7.38a/b 3.20 
M7 Dimer C26H35O4N4Cl3 573.1804 287.0941 1 10.09 7.60 3.36 
 
